{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:36:47Z","timestamp":1768261007458,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.pbb.2004.03.006","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T11:37:11Z","timestamp":1084016231000},"page":"143-153","source":"Crossref","is-referenced-by-count":64,"title":["Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"78","author":[{"given":"Rumiko","family":"Kurosaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2004.03.006_BIB1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2004.03.006_BIB2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","article-title":"Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-2,3,6-tetrahydropyridine(MPTP)-treated mouse","volume":"12","author":"Araki","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.pbb.2004.03.006_BIB3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","article-title":"Neuroprotective effect of riluzole in MPTP-treated mice","volume":"918","author":"Araki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.03.006_BIB4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0924-977X(01)00077-3","article-title":"Nitric oxide synthase inhibitors cause motor deficits in mice","volume":"11","author":"Araki","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/glia.440070117","article-title":"Cytotoxicity of microglia","volume":"7","author":"Banati","year":"1993","journal-title":"GLIA"},{"key":"10.1016\/j.pbb.2004.03.006_BIB6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pbb.2004.03.006_BIB7","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1523\/JNEUROSCI.17-17-06761.1997","article-title":"Dopaminergic neurons intrinsic to the primate striatum","volume":"17","author":"Betarbe","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.03.006_BIB8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0079-6603(08)60843-0","article-title":"Superoxide dismutases","volume":"40","author":"Beyer","year":"1991","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB9","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism","volume":"60","author":"Chiueh","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1","article-title":"Immunocytochemical localization of the dopamine transporter in human brain","volume":"409","author":"Ciliax","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.pbb.2004.03.006_BIB12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","article-title":"Altered brain metabolism of iron as a cause of neurodegenerative diseases?","volume":"63","author":"Gerlach","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1985.tb07120.x","article-title":"Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse","volume":"44","author":"Hallman","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB15","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1046\/j.1471-4159.1994.63051987.x","article-title":"Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease","volume":"63","author":"Hartley","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.pbb.2004.03.006_BIB17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03159727","article-title":"Some futures of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse","volume":"10","author":"Heikkila","year":"1989","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.03.006_BIB19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(95)01120-X","article-title":"1-Methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms","volume":"704","author":"Itano","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.03.006_BIB20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/jcbfm.1995.7","article-title":"Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance","volume":"15","author":"Kato","year":"1995","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pbb.2004.03.006_BIB21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/S0024-3205(97)01007-2","article-title":"Effects of l-DOPA and bromocriptine on haloperidol-induced motor deficits in mice","volume":"61","author":"Kobayashi","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.03.006_BIB22","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","article-title":"1-Benzyl-1,2,3,4-tetrahydroisoquinoline as parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkisonian CSF","volume":"65","author":"Kotake","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1179\/016164102101200717","article-title":"Role of nitric oxide synthase against MPTP neurotoxicity in mice","volume":"24","author":"Kurosaki","year":"2002","journal-title":"Neurol. Res."},{"key":"10.1016\/j.pbb.2004.03.006_BIB24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0197-4580(02)00085-4","article-title":"Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice","volume":"24","author":"Kurosaki","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbb.2004.03.006_BIB25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/mol.54.5.789","article-title":"1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis","volume":"54","author":"Leist","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2004.03.006_BIB27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/jcbfm.1991.162","article-title":"The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia","volume":"11","author":"Morioka","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pbb.2004.03.006_BIB28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1020025805287","article-title":"Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice","volume":"17","author":"Muramatsu","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pbb.2004.03.006_BIB29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000116351","article-title":"MPTP-induced parkinsonian model in mice: biochemistry, pharmacology, and behavior","volume":"26","author":"Ogawa","year":"1987","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB30","series-title":"The mouse brain in strereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.pbb.2004.03.006_BIB31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(86)90905-4","article-title":"Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment","volume":"376","author":"Ricaurte","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.03.006_BIB32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","article-title":"The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice","volume":"129","author":"Sonsalla","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB33","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1177\/38.11.2212623","article-title":"An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4)","volume":"38","author":"Streit","year":"1990","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(99)01209-3","article-title":"Differential vulnerability of dopamine receptors in the mouse brain treated by MPTP","volume":"824","author":"Tanji","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.03.006_BIB35","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1471-4159.1991.tb06407.x","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities","volume":"57","author":"Tasaki","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.03.006_BIB38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson's disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pbb.2004.03.006_BIB39","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1016\/S0021-9258(19)43735-6","article-title":"Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localization","volume":"248","author":"Weisiger","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2004.03.006_BIB40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.03.006_BIB41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0404.1989.tb01782.x","article-title":"Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?","volume":"126","author":"Youdim","year":"1989","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.pbb.2004.03.006_BIB42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/exnr.1994.1079","article-title":"In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity","volume":"127","author":"Zuddas","year":"1994","journal-title":"Exp. Neurol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T11:38:00Z","timestamp":1623929880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305704000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0091305704000735"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2004.03.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}